Role of Hippo-YAP Pathway in Smooth Muscle Phenotypic Modulation
Hippo-YAP 通路在平滑肌表型调节中的作用
基本信息
- 批准号:8403797
- 负责人:
- 金额:$ 33.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-01-01 至 2016-12-31
- 项目状态:已结题
- 来源:
- 关键词:AblationAdenovirusesAffectAmericanAngioplastyApoptosisArterial InjuryAtherosclerosisAttenuatedBindingBiological AssayBlood VesselsBoxingCardiovascular DiseasesCardiovascular systemCarotid ArteriesCell NucleusCell ProliferationCellsContractile ProteinsCytoplasmDataDiseaseDominant-Negative MutationDrosophila genusFamily memberFoundationsGelGene ExpressionGenesGoalsHypertensionImmunohistochemistryIn VitroInjuryKnockout MiceLesionLigandsMammalsMeasuresMediatingModelingMusMuscle DevelopmentNuclear ImportOrgan SizePathologyPathway interactionsPhenotypePhosphotransferasesPlayPreventionProteinsRattusRegulationRelative (related person)ReporterReporter GenesResearchRoleSerum Response FactorSignal PathwaySignal TransductionSmall Interfering RNASmooth MuscleSmooth Muscle MyocytesStimulusSubfamily lentivirinaeTherapeutic AgentsTissuesUp-RegulationVascular DiseasesVascular Smooth MuscleWestern BlottingWorkcell dedifferentiationcofactordesignin vivoinjuredinsightknock-downloss of functionmembermigrationmortalitymutantmyocardinnovelpreventpromoterprotein expressionprotein functionresearch studyrestenosissmall hairpin RNAtherapeutic targettranscription factortumorigenesisupstream kinasevascular smooth muscle cell migration
项目摘要
The overall goal of the proposed research is to determine the novel mechanisms by which the Hippo signaling
pathway regulates the phenotypic modulation of vascular smooth muscle cells (SMCs). Unraveling the
mechanisms involved in smooth muscle phenotypic switching is an important step towards better
understanding the pathology of smooth muscle-related vascular diseases. The Hippo signaling pathway is
evolutionarily conserved from Drosophila to mammals and plays a critical role in controlling organ size and
tumorigenesis by regulating cell proliferation and apoptosis. In mammals, cell contact and other unknown
mechanisms activate the Hippo pathway core component Mst1/2 kinases to phosphorylate and activate
Lats1/2 kinases, which in turn directly phosphorylate the transcriptional regulator YAP. Phosphorylated YAP is
retained in cytoplasm whereas unphosphorylated form of YAP translocates into the nucleus where it binds with
various transcription factors, to regulate gene expression required for control of cell proliferation and apoptosis.
Our preliminary data indicate expression of Hippo-YAP pathway components in vascular smooth muscle and a
novel role of Hippo-YAP pathway in phenotypic modulation. Experiments described in this proposal will
critically evaluate the hypothesis that the Hippo-YAP pathway plays an integrative role in smooth muscle
phenotypic modulation. In Aim 1, first we will knock down YAP expression in a rat carotid artery balloon injury
model through transduction with a YAP shRNA adenovirus to determine the role of YAP in vascular lesion
formation. Then we will investigate the functional role of YAP in smooth muscle development in vivo by
generating a smooth muscle-specific YAP knock-out mouse. In Aim 2, we will define the role of Hippo pathway
components in regulating smooth muscle phenotypic modulation. Studies are proposed to investigate the
function of Hippo pathway core components, Mst1/2 and Lats1/2 in SMC phenotypic modulation by gain- and
loss-of-function assays in SMCs and determine the relative importance of YAP up-regulation versus activated
Hippo pathway signaling and negative regulation of YAP during vascular injury by using rat balloon injury
model. In Aim 3, we will determine the mechanism by which YAP modulates smooth muscle phenotype.
Preliminary data demonstrate that YAP interaction with PY motif containing transcription factors is dispensable
for its function while the interaction with TEADs is essential for YAP to abrogate smooth muscle gene
expression through abolishing SRF binding to CArG box within smooth muscle gene promoters. Therefore we
will determine the role of TEADs in Hippo-YAP mediated smooth muscle phenotypic modulation and its
underlying mechanism by gel shift, co-IP, reporter and ChIP assays. Completion of these studies will provide
new insights into the mechanisms controlling smooth muscle differentiation and phenotypic modulation and
identify members of the Hippo pathway that may be appropriate therapeutic targets for ameliorating vascular
diseases.
拟议研究的总体目标是确定Hippo信号转导的新机制。
信号通路调节血管平滑肌细胞(SMC)的表型调节。 Unraveling the
参与平滑肌表型转换的机制是朝着更好的
了解平滑肌相关血管疾病的病理学。 河马信号通路是
从果蝇到哺乳动物进化上保守,在控制器官大小和
通过调节细胞增殖和凋亡来调节肿瘤的发生。 在哺乳动物中,细胞接触和其他未知的
机制激活Hippo途径核心组分Mst 1/2激酶磷酸化并激活
Lats 1/2激酶,其又直接磷酸化转录调节因子雅普。磷酸化的雅普是
保留在细胞质中,而非磷酸化形式的雅普易位到细胞核中,在那里它与
各种转录因子,以调节控制细胞增殖和凋亡所需的基因表达。
我们的初步数据表明,Hippo-YAP通路组分在血管平滑肌中的表达,
Hippo-YAP通路在表型调节中的新作用。 本提案中描述的实验将
批判性地评估Hippo-YAP通路在平滑肌中起整合作用的假设
表型调节在目标1中,首先我们将在大鼠颈动脉球囊损伤中敲低雅普表达
通过用雅普shRNA腺病毒转导的模型来确定雅普在血管损伤中的作用
阵 然后,我们将研究雅普在体内平滑肌发育中的功能作用,
产生平滑肌特异性雅普敲除小鼠。在目标2中,我们将定义Hippo通路的作用,
调节平滑肌表型调节的组分。 建议开展研究,
Hippo通路核心组分Mst 1/2和Lats 1/2在SMC表型调节中的功能,
SMC中的功能丧失测定,并确定雅普上调与活化的
大鼠血管球囊损伤中Hippo信号通路与雅普的负性调节
模型 在目标3中,我们将确定雅普调节平滑肌表型的机制。
初步数据表明,雅普与含有PY基序的转录因子的相互作用是不稳定的。
而与TEAD的相互作用是雅普消除平滑肌基因的必要条件
通过消除SRF与平滑肌基因启动子内的CArG盒的结合来表达。因此我们
将确定TEAD在Hippo-YAP介导的平滑肌表型调节中的作用,
通过凝胶迁移、co-IP、报告基因和ChIP测定的潜在机制。完成这些研究将提供
对控制平滑肌分化和表型调节的机制的新见解,
确定Hippo通路的成员,这些成员可能是改善血管紧张素转换酶活性的适当治疗靶点。
疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiliang Zhou其他文献
Jiliang Zhou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiliang Zhou', 18)}}的其他基金
PIK3C3, a master regulator for smooth muscle identity
PIK3C3,平滑肌特性的主调节器
- 批准号:
10531615 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
PIK3C3, a master regulator for smooth muscle identity
PIK3C3,平滑肌特性的主调节器
- 批准号:
10367668 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
The novel smooth muscle-specific lncRNA CARMN is a critical regulator of smooth muscle phenotype
新型平滑肌特异性 lncRNA CARMN 是平滑肌表型的关键调节因子
- 批准号:
10543860 - 财政年份:2020
- 资助金额:
$ 33.75万 - 项目类别:
The novel smooth muscle-specific lncRNA CARMN is a critical regulator of smooth muscle phenotype
新型平滑肌特异性 lncRNA CARMN 是平滑肌表型的关键调节因子
- 批准号:
10327633 - 财政年份:2020
- 资助金额:
$ 33.75万 - 项目类别:
Novel role of the lncRNA NEAT1 in smooth muscle phenotypic modulation
lncRNA NEAT1在平滑肌表型调节中的新作用
- 批准号:
9251903 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别:
Role of Hippo-YAP Pathway in Smooth Muscle Phenotypic Modulation
Hippo-YAP 通路在平滑肌表型调节中的作用
- 批准号:
8600720 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
Role of Hippo-YAP Pathway in Smooth Muscle Phenotypic Modulation
Hippo-YAP 通路在平滑肌表型调节中的作用
- 批准号:
8991508 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
Role of Hippo-YAP Pathway in Smooth Muscle Phenotypic Modulation
Hippo-YAP 通路在平滑肌表型调节中的作用
- 批准号:
8246228 - 财政年份:2012
- 资助金额:
$ 33.75万 - 项目类别:
相似海外基金
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10557162 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Molecular therapy of replication-competent adenoviruses targeting characteristic gene mutations found in mesothelioma
针对间皮瘤中发现的特征基因突变的具有复制能力的腺病毒的分子疗法
- 批准号:
21K08199 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Glioma therapy with oncolytic adenoviruses and immunometabolic adjuvants
溶瘤腺病毒和免疫代谢佐剂治疗胶质瘤
- 批准号:
10330464 - 财政年份:2021
- 资助金额:
$ 33.75万 - 项目类别:
Structural characterization of nucleoprotein cores of human adenoviruses
人腺病毒核蛋白核心的结构表征
- 批准号:
9807741 - 财政年份:2019
- 资助金额:
$ 33.75万 - 项目类别:
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2018
- 资助金额:
$ 33.75万 - 项目类别:
Discovery Grants Program - Individual
The therapeutic strategies with augmented replications of oncolytic adenoviruses for malignant mesothelioma
溶瘤腺病毒增强复制治疗恶性间皮瘤的治疗策略
- 批准号:
18K15937 - 财政年份:2018
- 资助金额:
$ 33.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular biology and pathogenesis of fowl adenoviruses
禽腺病毒的分子生物学和发病机制
- 批准号:
41625-2013 - 财政年份:2017
- 资助金额:
$ 33.75万 - 项目类别:
Discovery Grants Program - Individual
Exploring the effects of nutrient deprivation on T cells and oncolytic adenoviruses, in order to create immune activators for tumour therapy
探索营养剥夺对 T 细胞和溶瘤腺病毒的影响,以创造用于肿瘤治疗的免疫激活剂
- 批准号:
1813152 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别:
Studentship
Research on detection of novel adenoviruses by genetic methods
新型腺病毒的基因检测研究
- 批准号:
16K09118 - 财政年份:2016
- 资助金额:
$ 33.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)